secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2024-03-13T23:59:59+00:00
Accession:  0001161697-24-000140
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.02, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KORU Medical reports Q4 rev $7.2M, FY net loss $13.7M; guides 2024 rev $31.2-32.2M
--------------------------------------------------------------------------------

- Q4 net revenues $7.2M (-2% YoY); gross margin improved to 60.3% (+470bps).
- Full year net loss $13.7M ($0.30/sh) includes $6M non-cash tax valuation allowance; Adjusted EBITDA ($6.0M) vs ($6.1M) prior year.
- Full year 2024 revenue guidance $31.2-32.2M (10-13% growth); gross margin 59-61%; cash flow breakeven in Q4 2024.
- Entered $10M credit facility with HSBC ($5M revolver + $5M term loan; undrawn); warrant for 76,104 shares at $2.12.
- EU notified body BSI recommended against continued certification; appeal filed; mgmt expects minimal revenue impact.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169724000140/0001161697-24-000140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169724000140/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-24-000140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer